ELIZABETH SCHAEFER
@State Street Corp
Latest period2024 - Q3ReportedManaged Assets$2.458TTotal holdings4296
Assets growth rate7.39%Assets growth rate (2-Q avg)4.85%Continuous growth in asset value4 quarters
Portfolio positions
This chart displays the top 10 holdings in State Street Corp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 4296 positions.
Assets under management
The assets under management (AUM) of State Street Corp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.458T in assets, with a quarterly growth rate of 7.39% and a 2-quarter average growth rate of 4.85%. The portfolio is managed by ELIZABETH SCHAEFER, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
VRTXVertex Pharmaceuticals Inc
| 0.23% | $5.496B 11.816M shares@ $465.09 avg price | Increased 0.77% |
SOSouthern Co
| 0.22% | $5.314B 58.929M shares@ $90.19 avg price | Increased 2.7% |
SYKStryker Corporation
| 0.22% | $5.28B 14.583M shares@ $362.06 avg price | Increased 2.22% |
BSXBoston Scientific Corp
| 0.22% | $5.267B 62.846M shares@ $83.8 avg price | Increased 2.27% |
ADIAnalog Devices Inc
| 0.22% | $5.195B 22.572M shares@ $230.18 avg price | Increased 0.48% |
EQIXEquinix Inc
| 0.22% | $5.171B 5.826M shares@ $887.64 avg price | Increased 1.43% |
REGNRegeneron Pharmaceuticals
| 0.21% | $5.154B 4.902M shares@ $1051.25 avg price | Increased 1.27% |
NKENike Inc
| 0.21% | $5.141B 57.917M shares@ $88.77 avg price | Increased 3.33% |
ADPAutomatic Data Processing In
| 0.21% | $5.099B 18.335M shares@ $278.09 avg price | Increased 2.37% |
GILDGilead Sciences Inc
| 0.21% | $5.045B 60.172M shares@ $83.84 avg price | Increased 1.42% |